SCHEMBL498707

SCHEMBL498707

CC(=O)c1ccc(Cl)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.58
MAOA P21397 2/20 0.58
ALDH1A1 P00352 2/20 0.55
CYP3A4 P08684 2/20 0.55
HPGD P15428 1/20 0.55
MAPK1 P28482 1/20 0.55
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
P2RX1 P51575 3/20 0.49
TMPRSS4 Q9NRS4 2/20 0.49
P2RX4 Q99571 1/20 0.49
P2RX7 Q99572 1/20 0.49
KLKB1 P03952 1/20 0.49
TSHR P16473 2/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PTPN1 P18031 1/20 0.48
PTGS2 P35354 1/20 0.48
PLAU P00749 2/20 0.47
F2 P00734 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495428 1.00 MAOB (0.58) MAOBMAOAALDH1A1CYP3A4HPGD
SCHEMBL11778899 0.91 KCNMA1 (0.51) MAOBMAOAALDH1A1CYP3A4HPGD
SCHEMBL218964 0.83 CA1 (0.67) MAOBMAOAHPGDMAPK1CA1
SCHEMBL27612735 0.82 CA1 (0.54) ALDH1A1CYP3A4MAPK1CA1CA2
SCHEMBL20117002 0.82 ALDH1A1 (0.50) MAOBMAOAALDH1A1MAPK1CA1
Bromide SCHEMBL30207997 0.81 CA1 (0.64) MAOBMAOAHPGDMAPK1CA1
Hydrochloric Acid SCHEMBL11784623 0.81 CA1 (0.64) MAOBMAOAHPGDMAPK1CA1
SCHEMBL29384783 0.80 TSHR (0.65) ALDH1A1CYP3A4MAPK1TSHRTDP1
SCHEMBL14439661 0.80 ALDH1A1 (0.48) MAOBMAOAALDH1A1MAPK1CA1
SCHEMBL4880939 0.80 CA1 (0.52) MAOBMAOAALDH1A1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116515782-A Amine dehydrogenase mutant and application thereof in chiral amine alcohol compound synthesis 中国科学院天津工业生物技术研究所 2023-08-01 CN claimed
CN-114146071-B Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome 西北农林科技大学深圳研究院 2023-02-28 CN claimed
CN-114751870-A 2- (isoxazole-5-yl) phenyl-3, 4-dihydroxy benzoate and derivative thereof, and synthesis method and application thereof 贵州医科大学 2022-07-15 CN claimed
CN-114146071-A Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome 西北农林科技大学深圳研究院 2022-03-08 CN claimed
EP-3253750-B1 NOVEL FLAVONE BASED EGFR INHIBITORS AND PROCESS FOR PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2019-04-10 EP claimed
US-10221165-B2 Flavone based EGFR inhibitors and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-05 US claimed
US-20180016268-A1 Novel Flavone Based EGFR Inhibitors and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-01-18 US claimed
WO-2016125186-A1 NOVEL FLAVONE BASED EGFR INHIBITORS AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-08-11 WO claimed
EP-4660194-A1 SALT AND CRYSTAL FORM OF CYCLOALKENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2025-12-10 EP disclosed
WO-2025217336-A1 CYSTEINE COVALENT MODIFIERS OF AKT1 AND USES THEREOF TERREMOTO BIOSCIENCES, INC. (US) 2025-10-16 WO disclosed
CN-118638089-B Preparation method for synthesizing flavonoid compound based on carbon dioxide 湖南工程学院 2024-11-12 CN disclosed
CN-118638089-A Preparation method for synthesizing flavonoid compound based on carbon dioxide 湖南工程学院 2024-09-13 CN disclosed
US-20240208986-A1 PHENYL AZEPINES AS RIPK1 INHIBITORS AND METHODS OF USE THEREOF MERCK SHARP & DOHME LLC (US) 2024-06-27 US disclosed
CN-117986264-A Benzo nitrogen-containing polycyclic derivative regulator and preparation method and application thereof 江苏豪森药业集团有限公司 2024-05-07 CN disclosed
US-4402968-A Antifungal benzofuranyl imidazole compounds HOFFMANN-LA ROCHE INC. (US) 1983-09-06 US disclosed
EP-0041673-A1 Imidazole derivatives, their preparation and compositions containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-12-16 EP disclosed
US-4265903-A HYPOTENSIVE, ADRENOLYTIC BEIERSDORF AKTIENGESELLSCHAFT (DE) 1981-05-05 US disclosed
US-4122256-A OPTICAL BRIGHTENERS HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-24 US disclosed
US-3994879-A CONDENSING AZOMETHINES, OPTICAL BRIGHTENERS HOECHST AKTIENGESELLSCHAFT (DT) 1976-11-30 US disclosed
US-3933918-A ANTITUSSIVE KYOWA HAKKO KOGYO CO., LTD. (JA) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016268-A1 Novel Flavone Based EGFR Inhibitors and Process for Preparation Thereof EGFR, ERBB2, ABL1 MAOB 1112/4885MAOA 1733/4885ALDH1A1 1959/4885
US-20240208986-A1 PHENYL AZEPINES AS RIPK1 INHIBITORS AND METHODS OF USE THEREOF RIPK1, RIPK2, RIPK4 MAOB 3715/4885MAOA 3315/4885ALDH1A1 4049/4885
US-10221165-B2 Flavone based EGFR inhibitors and process for preparation thereof EGFR, ERBB2, ABL1 MAOB 1202/4885MAOA 1685/4885ALDH1A1 2054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.